214 related articles for article (PubMed ID: 11985633)
1. Ropinirole for the treatment of tremor in early Parkinson's disease.
Schrag A; Keens J; Warner J;
Eur J Neurol; 2002 May; 9(3):253-7. PubMed ID: 11985633
[TBL] [Abstract][Full Text] [Related]
2. Ropinirole: a review of its use in the management of Parkinson's disease.
Matheson AJ; Spencer CM
Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: a multicenter, double-blind, randomized, placebo-controlled study.
Zhang Z; Wang J; Zhang X; Chen S; Wang Z; Zhang B; Liu C; Qu Q; Cheng Y; Li J; Cao H; Cai M; Zhu R
Parkinsonism Relat Disord; 2013 Nov; 19(11):1022-6. PubMed ID: 23932066
[TBL] [Abstract][Full Text] [Related]
4. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Im JH; Ha JH; Cho IS; Lee MC
J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
[TBL] [Abstract][Full Text] [Related]
5. Switching from bromocriptine to ropinirole in patients with advanced Parkinson's disease: open label pilot responses to three different dose-ratios.
Giménez-Roldán S; Esteban EM; Mateo D
Clin Neuropharmacol; 2001; 24(6):346-51. PubMed ID: 11801810
[TBL] [Abstract][Full Text] [Related]
6. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Brunt ER; Brooks DJ; Korczyn AD; Montastruc JL; Stocchi F;
J Neural Transm (Vienna); 2002 Apr; 109(4):489-502. PubMed ID: 11956968
[TBL] [Abstract][Full Text] [Related]
7. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group.
Lieberman A; Olanow CW; Sethi K; Swanson P; Waters CH; Fahn S; Hurtig H; Yahr M
Neurology; 1998 Oct; 51(4):1057-62. PubMed ID: 9781529
[TBL] [Abstract][Full Text] [Related]
8. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group.
Korczyn AD; Brunt ER; Larsen JP; Nagy Z; Poewe WH; Ruggieri S
Neurology; 1999 Jul; 53(2):364-70. PubMed ID: 10430427
[TBL] [Abstract][Full Text] [Related]
9. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C
Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304
[TBL] [Abstract][Full Text] [Related]
10. Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
Rascol O; Lees AJ; Senard JM; Pirtosek Z; Montastruc JL; Fuell D
Clin Neuropharmacol; 1996 Jun; 19(3):234-45. PubMed ID: 8726542
[TBL] [Abstract][Full Text] [Related]
11. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Korczyn AD; Brooks DJ; Brunt ER; Poewe WH; Rascol O; Stocchi F
Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325
[TBL] [Abstract][Full Text] [Related]
12. A randomized, fixed-dose, dose-response study of ropinirole prolonged release in advanced Parkinson's disease.
Zesiewicz TA; Chriscoe S; Jimenez T; Upward J; Davy M; VanMeter S
Neurodegener Dis Manag; 2017 Feb; 7(1):61-72. PubMed ID: 28120630
[TBL] [Abstract][Full Text] [Related]
13. Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study.
Mizuno Y; Nomoto M; Hasegawa K; Hattori N; Kondo T; Murata M; Takeuchi M; Takahashi M; Tomida T;
Parkinsonism Relat Disord; 2014 Dec; 20(12):1388-93. PubMed ID: 25455692
[TBL] [Abstract][Full Text] [Related]
14. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
Buchwald B; Angersbach D; Jost WH
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
[TBL] [Abstract][Full Text] [Related]
15. Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis.
Zhao H; Ning Y; Cooper J; Refoios Camejo R; Ni X; Yi B; Parks D
Adv Ther; 2019 Jun; 36(6):1252-1265. PubMed ID: 30963514
[TBL] [Abstract][Full Text] [Related]
16. Ropinirole therapy for Parkinson's disease.
Pahwa R; Lyons KE; Hauser RA
Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
Tompson D; Oliver-Willwong R
Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
[TBL] [Abstract][Full Text] [Related]
18. Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study.
Stocchi F; Hersh BP; Scott BL; Nausieda PA; Giorgi L;
Curr Med Res Opin; 2008 Oct; 24(10):2883-95. PubMed ID: 18768106
[TBL] [Abstract][Full Text] [Related]
19. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F
Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
Pogarell O; Gasser T; van Hilten JJ; Spieker S; Pollentier S; Meier D; Oertel WH
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):713-20. PubMed ID: 12023411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
